Measuring the impact of MS on walking ability: The 12-item MS Walking Scale (MSWS-12)

Neurology

Volumn 60, Issue 1, 2003, Pages 31-36

  Hobart, J C ^a   Riazi, A ^b   Lamping, D L ^b   Fitzpatrick, R ^b   Thompson, A J ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERVIEW; LOCOMOTION; MALE; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RELIABILITY; VALIDATION PROCESS; WALKING;

EID: 0037435521     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.31     Document Type: Article

References (32)

1. Martin J, Meltzer M, Elliot D. OPCS surveys of disability in Great Britain. Report 1: the prevalence of disability among adults. London: Her Majesty's Stationary Office, 1988.
2. Chiou IL, Burnett CN. Values of activities of daily living: a survey of stroke patients and their home therapists. Arch Phys Med Rehabil 1985;65:901-906.
3. Swingler R, Compston DAS. The morbidity of multiple sclerosis. Q J Med 1992;83:325-337.
4. Hobart JC, Lamping DL, Fitzpatrick R, Riazi A, Thompson AJ. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001;124:962-973.
5. Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992.
6. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-180.
7. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
8. Confavreux C, Compston DAS, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:671-676.
9. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey manual and interpretation guide. Boston: Nimrod Press, 1993.
10. Cella DF, Dineen K, Arnason B, et al. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology 1996;47:129-139.
11. Sharrack B, Hughes RAC. The Guy's Neurological Disability Scale (GNDS), a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-233.
12. Singh A, Crockard HA. Quantitative assessment of cervical spondylotic myelopathy by a simple walking test. Lancet 1999;354:370-373.
13. Hobart JC, Freeman JA, Thompson AJ. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000;123:1027-1040.
14. Hobart JC, Freeman JA, Lamping DL, Fitzpatrick R, Thompson AJ. The SF-36 in multiple sclerosis (MS): why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 2001;71:363-370.
15. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.
16. McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 1994;32:40-66.
17. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966;19:3-11.
18. Likert RA. A technique for the development of attitudes. Arch Psychol 1932;140:5-55.
19. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
20. Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull 1955;52:281-302.
21. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-S189.
22. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-638.
23. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-547.
24. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991;12:142S-158S.
25. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
26. Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 1992;45:743-760.
27. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. Br Med J 1997;314:1580-1583.
28. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med Care 1988;26:724-735.
29. Hobart JC, Lamping DL, Freeman JA, et al. Evidence-based measurement: which disability scale for neurological rehabilitation? Neurology 2001;57:639-644.
30. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960.
31. Lord FM, Novick MR. Statistical theories of mental test scores. Reading, MA: Addison-Wesley, 1968.
32. Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997;42:379-382.